Meet our partners
Global Partner
GlaxoSmithKline
Britain's largest multinational pharmaceutical company with a prolific track record in R&D and a wide portfolio of products for consumer healthcare and major disease areas. Read more at gsk.com
News

Mar 2016 GSK receives marketing authorisation for Nucala® (mepolizumab) in Japan

Feb 2016 GSK’s global HIV business ViiV Healthcare completes transactions to acquire Bristol-Myers Squibb’s R&D HIV assets

Oct 2015 GlaxoSmithKline beats sales forecasts thanks to HIV drugs boost

From the OneStart London Bootcamp 2015

Panel Discussion 

Panel Discussion: Case Studies from Life Science Companies

  • Jeanne Bolger, VP Venture Investing, Johnson & Johnson Innovation- JJDC (Chair)
  • Chris Brown, MBA, Director, Scientific Licensing, Worldwide Business Development, GSK
  • Ilan Zipkin, PhD, Senior Investment Director, Takeda Ventures
  • Sarah Holland, DPhil(Oxon), MBA, Life Cycle Leader alectinib, Roche
  • Lynne Murray, PhD, MBA, Partnering & Strategy, MedImmune

Mentors
Chris Brown
Director, Worldwide Business Development, GSK + more
I joined GSK as Director, Worldwide Business Development in 2011. Prior to that I was Director, Worldwide Business Development at Pfizer.
Rick Cousins
Senior Director, Alternative Discovery & Development, GSK + more
I am leading the creation of a new pre-Discovery Performance Unit (DPU) at GSK hearing disorders within the Alternative Discovery & Development organisation at Stevenage. I have been involved in programmes at all stages of drug discovery on a wide variety of targets for many therapeutic areas including anti-virals, anti-fungals, cardiovascular, respiratory, inflammation, neurology and metabolism.
Veronique Birault
Director, Respiratory Therapeutic Area, GSK + more
I have 14 years of pharmaceutical drug discovery and development experience. I am a medicinal chemist by training with experience in developing molecules and antibodies from discovery through clinical development mainly in immuno-inflammation and respiratory diseases. Prior to GSK, I spent 6 years at BioFocus DPI, a UK based CRO providing research to the pharmaceutical industry. During my career I have led multidisciplinary teams / unit (with medicinal chemists, biologists, physicians and pharmacologists) , lead academic/ industry drug discovery collaborations, define strategies and deliver success.
Teams Mentored